The general evaluation of CYBERDYNE (JP), a company active in the Medical Equipment industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date April 5, 2022, the closing price was JPY 3...
The PSA Japan Research Round-Up for the week ending February 16, 2018 Contents at a Glanceï¶ The Weekly Comment by Pelham Smithers: Surf’s up: Pelham Smithers considers whether we are starting to see a break in the link between the yen and the Japanese stock market.ï¶ Reports / Flash Notes Summaries 1. Mitsubishi Electric (6503 JP): FA and Infrastructure Upturn 2. Sony (6758 JP): FY17 Outlook and SoTP5ï¶ Company / Sector / Thematic Comments 1. Sony (6758 JP) Surprises, Irritates with Peter Ra...
PSA Today Feb 16: Japan Market Comment by Pelham Smithers, Joel Scheiman, William Nestuk and Thao NguyenNikkei ¥21,720.25 (+¥255.27/ +1.19%); Topix ¥1,737.37(+¥18.10 / +1.05%); ¥/$105.80Tags: iStyle (3660 JP), Kitanotatsujin (2930 JP), Shiseido (4911 JP), Capcom (9697 JP), NEC (6701 JP), Cyberdyne (7779 JP), Daiwa House (1925 JP), Mitsui Chemical (4183 JP) Bayer (BAYN GR), Daikin (6367 JP), Start Today (ST, 3092 JP)Main Points at a Glance • Japanese shares higher, led by domestic demand names • ...
Going back some eighteen months, when issuing “short sell” reports was all the rage in Japan, a favourite stock to target was Cyberdyne, which at that time was trading on a Price : Sales ratio of 400x. In response, PSA made a case for Cyberdyne being a “sell” or an “avoid”, but noted that a short-sell recommendation is a different matter altogether, involving as it does (1) the reader proactively positioning in the stock; and (2) requiring an endgame that triggers position unwinding. Such an end...
Not gone unnoticed in Intel’s (INTC US) US$63/share bid for Mobileye (MBLY US) ($60.96 as close of play on Mar 14th; YTD the stock has risen by 60%) is the fact that just under twelve months ago, Mobileye was the subject of a high profile short sell report by Citron Research who valued the stock at US$11/shr; a view the firm unfortunately repeated only last month. Now, unless shareholders of Intel can convince management somehow to pull that bid, this is one of those terminal situations that see...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.